Patents Assigned to MIGVAX LTD.
  • ORAL COMPOSITIONS AND USE OF SAME IN VACCINATION
    Publication number: 20240197864
    Abstract: The present invention is directed to a method for increasing immunization efficiency of a subject to a pathogen, including administering a therapeutically effective amount of a pharmaceutical composition including: (a) a heat labile toxin subunit B (LTB) polypeptide or a functional analog thereof, and (b) an immunogenic polypeptide derived from the pathogen.
    Type: Application
    Filed: February 24, 2022
    Publication date: June 20, 2024
    Applicant: MIGVAX LTD.
    Inventors: Sigal KREMER-TAL, Morris LASTER, Jacob PITCOVSKI